Martha Storandt
Affiliations: | Psychology | Washington University, Saint Louis, St. Louis, MO |
Area:
Clinical Psychology, Personality Psychology, GerontologyGoogle:
"Martha Storandt"Mean distance: 17811
Parents
Sign in to add mentorJack Botwinick | grad student | Washington University | |
Robert Kleemeier | grad student | Washington University |
Children
Sign in to add trainee
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Storandt M, Balota DA, Aschenbrenner AJ, et al. (2014) Clinical and psychological characteristics of the initial cohort of the Dominantly Inherited Alzheimer Network (DIAN). Neuropsychology. 28: 19-29 |
Williams MM, Storandt M, Roe CM, et al. (2013) Progression of Alzheimer's disease as measured by Clinical Dementia Rating Sum of Boxes scores. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: S39-44 |
Storandt M, Head D, Fagan AM, et al. (2012) Toward a multifactorial model of Alzheimer disease. Neurobiology of Aging. 33: 2262-71 |
Johnson D, Galvin J, Storandt M. (2012) P3-080: Mild cognitive impairment in Parkinson's disease dementia Alzheimer's & Dementia. 8: P480-P481 |
Xiong C, Roe CM, Buckles V, et al. (2011) Role of family history for Alzheimer biomarker abnormalities in the adult children study. Archives of Neurology. 68: 1313-9 |
Galvin JE, Fagan AM, Holtzman DM, et al. (2010) IC-P-007: Correlation of the AD8: an Informant-Based Dementia Screening Tool with Amyloid Imaging and CSF Biomarkers of Alzheimer Disease Alzheimer's & Dementia. 6: S8-S9 |
Cairns NJ, Ikonomovic MD, Benzinger T, et al. (2009) Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report. Archives of Neurology. 66: 1557-62 |
Storandt M, Mintun MA, Head D, et al. (2009) Cognitive decline and brain volume loss as signatures of cerebral amyloid-beta peptide deposition identified with Pittsburgh compound B: cognitive decline associated with Abeta deposition. Archives of Neurology. 66: 1476-81 |
Morris JC, Roe CM, Grant EA, et al. (2009) Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Archives of Neurology. 66: 1469-75 |
Johnson DK, Storandt M, Morris JC, et al. (2009) Longitudinal study of the transition from healthy aging to Alzheimer disease. Archives of Neurology. 66: 1254-9 |